|
Volumn 21, Issue 4, 2002, Pages 657-663
|
Predictive factors for response to neoadjuvant therapy in patients with oesophageal cancer
|
Author keywords
Neoadjuvant therapy; Oesophageal cancer; Predictive factors
|
Indexed keywords
CD34 ANTIGEN;
CISPLATIN;
FLUOROURACIL;
VASCULOTROPIN;
ADJUVANT THERAPY;
ADULT;
AGED;
ARTICLE;
CELL PROLIFERATION;
ESOPHAGUS CANCER;
FEMALE;
HUMAN;
IMMUNOHISTOCHEMISTRY;
MAJOR CLINICAL STUDY;
MALE;
MULTIVARIATE ANALYSIS;
OUTCOMES RESEARCH;
PREDICTION;
PRIORITY JOURNAL;
PROGNOSIS;
SURVIVAL RATE;
ADENOCARCINOMA;
ADULT;
AGED;
ANTIBODIES;
ANTIGENS, NUCLEAR;
BIOPSY;
CARCINOMA, SQUAMOUS CELL;
CHEMOTHERAPY, ADJUVANT;
ENDOTHELIAL GROWTH FACTORS;
ENDOTHELIUM, VASCULAR;
ESOPHAGEAL NEOPLASMS;
ESOPHAGUS;
FEMALE;
GERMANY;
HUMANS;
KI-67 ANTIGEN;
LYMPHOKINES;
MALE;
MIDDLE AGED;
MULTIVARIATE ANALYSIS;
NEOADJUVANT THERAPY;
NEOPLASM STAGING;
NUCLEAR PROTEINS;
PREDICTIVE VALUE OF TESTS;
PREOPERATIVE CARE;
RADIOTHERAPY, ADJUVANT;
STATISTICS;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
|
EID: 0036206713
PISSN: 10107940
EISSN: None
Source Type: Journal
DOI: 10.1016/S1010-7940(02)00044-1 Document Type: Article |
Times cited : (51)
|
References (25)
|